Newron Pharmaceuticals
NWRN.SW
#8336
Rank
NZ$0.28 B
Marketcap
$14.38
Share price
-0.42%
Change (1 day)
2.18%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -NZ$30.05 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.01 Million. In 2023 the company made an earning of -NZ$30.05 Million, an increase over its 2022 earnings that were of -NZ$31.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-NZ$30.05 Million-4.45%
2022-NZ$31.44 Million11.19%
2021-NZ$28.28 Million-30.14%
2020-NZ$40.48 Million6.84%
2019-NZ$37.89 Million31.45%
2018-NZ$28.83 Million170.13%
2017-NZ$10.67 Million-60.23%
2016-NZ$26.83 Million-41.46%
2015-NZ$45.83 Million109.46%
2014-NZ$21.88 Million22.43%
2013-NZ$17.87 Million222.49%
2012-NZ$5.55 Million-60.49%
2011-NZ$14.03 Million-71%
2010-NZ$48.36 Million-17.37%
2009-NZ$58.53 Million52.58%
2008-NZ$38.36 Million41.24%
2007-NZ$27.16 Million-25.19%
2006-NZ$36.31 Million22.45%
2005-NZ$29.65 Million